Stifel Financial
NVCR icon

Stifel Financial’s NovoCure NVCR Stock Holding History

Stifel Financial’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,537
Closed -$479K – 3399
2022
Q4 		$479K Sell
6,537
-474
-7% -$35.7K ﹤0.01% 2495
2022
Q3 		$532K Sell
7,011
-182
-3% -$14.2K ﹤0.01% 2395
2022
Q2 		$499K Sell
7,193
-95
-1% -$7.16K ﹤0.01% 2466
2022
Q1 		$604K Sell
7,288
-807
-10% -$59.4K ﹤0.01% 2469
2021
Q4 		$608K Sell
8,095
-1,984
-20% -$199K ﹤0.01% 2484
2021
Q3 		$1.17M Buy
10,079
+1,156
+13% +$175K ﹤0.01% 1965
2021
Q2 		$1.98M Buy
8,923
+858
+11% +$167K ﹤0.01% 1621
2021
Q1 		$1.07M Sell
8,065
-1,982
-20% -$314K ﹤0.01% 1946
2020
Q4 		$1.74M Buy
10,047
+1,234
+14% +$169K ﹤0.01% 1471
2020
Q3 		$981K Sell
8,813
-375
-4% -$30K ﹤0.01% 1647
2020
Q2 		$545K Buy
9,188
+1,094
+14% +$72K ﹤0.01% 1984
2020
Q1 		$543K Buy
8,094
+3,309
+69% +$262K ﹤0.01% 1811
2019
Q4 		$405K Sell
4,785
-13,657
-74% -$1.1M ﹤0.01% 2386
2019
Q3 		$1.38M Sell
18,442
-1,760
-9% -$141K ﹤0.01% 1553
2019
Q2 		$1.27M Sell
20,202
-9,010
-31% -$457K ﹤0.01% 1651
2019
Q1 		$1.41M Sell
29,212
-2,685
-8% -$129K ﹤0.01% 1450
2018
Q4 		$1.07M Hold
31,897
– – ﹤0.01% 1482
2018
Q3 		$1.67M Sell
31,897
-5,000
-14% -$199K ﹤0.01% 1359
2018
Q2 		$1.15M Sell
36,897
-17,170
-32% -$478K ﹤0.01% 1520
2018
Q1 		$1.18M Sell
54,067
-5,859
-10% -$126K ﹤0.01% 1459
2017
Q4 		$1.21M Sell
59,926
-29,540
-33% -$569K ﹤0.01% 1401
2017
Q3 		$1.78M Buy
+89,466
New +$1.76M 0.01% 1185

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NA
Nordwand Advisors Radnor, Pennsylvania $572M AUM 23.09% 1-Year Est. Return

Stifel Financial's NVCR Position: Q1 2023 in Review

Stifel Financial sold out of NovoCure (NVCR) in Q1 2023, closing a stake of 6,537 shares — an estimated $479K sold.

Stifel Financial first reported a position in NVCR in Q3 2017 and held it in 22 quarters. The position peaked at $1.98M in Q2 2021. 295 funds tracked by Wall St. Rank hold NVCR as of Q1 2023.

  • Stifel Financial reported no remaining NovoCure position as of Q1 2023 after selling out during the quarter.
  • Stifel Financial sold 6,537 NovoCure shares in Q1 2023, an estimated $479K.
  • Stifel Financial first reported a position in NovoCure in Q3 2017 and held it in 22 quarters.
  • Stifel Financial's NovoCure position peaked at $1.98M in Q2 2021.
  • 295 funds tracked by Wall St. Rank held NovoCure as of Q1 2023.

Based on Stifel Financial's 13F filing for Q1 2023, filed 12 May 2023.